NCT07442474

Brief Summary

The goal of this observational study is to evaluate the diagnostic accuracy of CBCT dose reduction on the mandibular canal visibility, and their effect on canal cortication compared to standard CBCT dose as a gold standard. The main question it aims to answer is: Will the lower CBCT doses affect the visualization of mandibular canal when compared to standard CBCT dose as a gold standard?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 4, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 23, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

February 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 2, 2026

Completed
Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

1.2 years

First QC Date

February 24, 2026

Last Update Submit

February 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary outcome Evaluation of the diagnostic accuracy of the lowest CBCT dose (Milliampere: 2.2 mA.) compared to the gold standard CBCT dose (Milliampere: 10 mA.) on the mandibular canal visibility.

    March 2024

Study Arms (6)

I1: Conventional dose CBCT imaging

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 8 mA. * Exposure time: 13.5s * Voxel size: 0.4 mm

Diagnostic Test: CBCT imaging

I2: Conventional dose CBCT imaging

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 5.6 mA. * Exposure time: 9 s * Voxel size: 0.6 mm

Diagnostic Test: CBCT imaging

I3: CBCT imaging with Ultra low dose

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 7.1 mA. * Exposure time: 6 s * Voxel size: 0.2 mm

Diagnostic Test: CBCT imaging

I4: CBCT imaging with Ultra low dose

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 5.6 mA. * Exposure time: 4.5s * Voxel size: 0.4 mm.

Diagnostic Test: CBCT imaging

I5: CBCT imaging with Ultra low dose

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 2.2 mA. * Exposure time: 4.5 s * Voxel size: 0.6 mm.

Diagnostic Test: CBCT imaging

R (Reference standard): CBCT imaging with standard dose

exposure parameters: * Kilovoltage: 90 kVp. * Milliampere: 10 mA. * Exposure time: 18s * Voxel size: 0.2 mm.

Diagnostic Test: CBCT imaging

Interventions

CBCT imagingDIAGNOSTIC_TEST

Each dry human mandible will be scanned 6 times (3 conventional CBCT protocols and 3 Ultra-low CBCT protocols)

I1: Conventional dose CBCT imagingI2: Conventional dose CBCT imagingI3: CBCT imaging with Ultra low doseI4: CBCT imaging with Ultra low doseI5: CBCT imaging with Ultra low doseR (Reference standard): CBCT imaging with standard dose

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Dry human mandibles that will be recruited from Anatomy Department, Faculty of Medicine, Cairo University.

You may qualify if:

  • sound mandibles

You may not qualify if:

  • fractured mandibles

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

February 24, 2026

First Posted

March 2, 2026

Study Start

January 4, 2023

Primary Completion

March 23, 2024

Study Completion

May 20, 2024

Last Updated

March 2, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations